A Pilot Study to Explore the Role of Gut Flora in Multiple Sclerosis

ProgenaBiome

Status: Withdrawn

Conditions: Multiple Sclerosis; MS

Treatments: Other: No Intervention

Study type: Observational

Funder types: Other

Identifiers

NCT04148313

PRG-017

Details and patient eligibility

About

This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding Multiple Sclerosis.

Full description

The goal of this Research Study is to better understand how the genetic information in subject's microbiome correlates to the information provided in surveys and in medical records regarding Multiple Sclerosis.

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study
2. Male or female patients of any age (interest is given to children to compare with mothers).

Diagnosis of Multiple Sclerosis.

Exclusion criteria

1. Refusal to sign informed consent form
2. History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy.
3. Postoperative stoma, ostomy, or ileoanal pouch
4. Participation in any experimental drug protocol within the past 12 weeks
5. Treatment with total parenteral nutrition
6. Any clinically significant evidence of disease that could interfere with the subject's ability to enter the trial
7. Inability to adequately communicate with the investigator or their respective designee and/or comply with the requirements of the entire study

Trial design

0 participants in 1 patient group

Patients

Description:

Patients with diagnosis of Multiple Sclerosis.

Treatment:

Other: No Intervention